Brie Carter

Imagion Biosystems (ASX:IBX) has secured central Institutional Review Board ethics approval from Advarra for its Phase 1b/2 clinical trial.

Treasury Wine Estates (ASX:TWE) has permanently appointed interim leader Justin Pipito as its Group CFO, effective Oct. 1.

Four Greek providers have entered the EU’s MiCA register for the first time.

Telix Pharmaceuticals (ASX:TLX) announced that the U.S. Food and Drug Administration granted a Fast Track designation for its BiPASS prostate cancer imaging programme.

Ethereum (ETH) has scheduled its Glamsterdam upgrade for Sepolia on 6 October 2026.

Metrics Credit Partners suspended investor redemptions across wholesale funds managing over $9 billion after slashing $168 million from the valuation of three listed vehicles.

L3Harris Technologies (NYSE:LHX) announced that it received an undefinitized contract from Lockheed Martin valued at more than $6 billion, excluding escalations, over seven years to expand propulsion production for the Terminal High Altitude Area Defense (THAAD) missile defense system.

Iovance Biotherapeutics (NASDAQ:IOVA) raised its full-year 2026 revenue guidance following stronger-than-expected demand for its commercial products, Amtagvi and Proleukin.

Caterpillar (NYSE:CAT) announced an agreement to acquire John Fabick Tractor Company, an independent Cat dealer serving customers across parts of the Midwest United States.

Invivyd (NASDAQ:IVVD) reported Phase 3 LIBERTY trial results showing that its investigational COVID-19 antibody product VYD2311 demonstrated fewer reported adverse events compared with an mRNA COVID-19 vaccine.